These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21969277)

  • 1. The optimal discovery procedure in multiple significance testing: an empirical Bayes approach.
    Noma H; Matsui S
    Stat Med; 2012 Jan; 31(2):165-76. PubMed ID: 21969277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical Bayes screening of many p-values with applications to microarray studies.
    Datta S; Datta S
    Bioinformatics; 2005 May; 21(9):1987-94. PubMed ID: 15691856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An empirical Bayes optimal discovery procedure based on semiparametric hierarchical mixture models.
    Noma H; Matsui S
    Comput Math Methods Med; 2013; 2013():568480. PubMed ID: 23690877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonparametric empirical Bayes framework for large-scale multiple testing.
    Martin R; Tokdar ST
    Biostatistics; 2012 Jul; 13(3):427-39. PubMed ID: 22085895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the optimal discovery procedure to genetic case-control studies: comparison with p values and asymptotic Bayes factors.
    Tachmazidou I; De Iorio M; Dudbridge F
    Hum Hered; 2011; 71(1):37-49. PubMed ID: 21389730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal detection of functional connectivity from high-dimensional EEG synchrony data.
    Singh AK; Asoh H; Phillips S
    Neuroimage; 2011 Sep; 58(1):148-56. PubMed ID: 21704709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resampling-based empirical Bayes multiple testing procedures for controlling generalized tail probability and expected value error rates: focus on the false discovery rate and simulation study.
    Dudoit S; Gilbert HN; van der Laan MJ
    Biom J; 2008 Oct; 50(5):716-44. PubMed ID: 18932138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of empirical Bayes hierarchical modeling for the analysis of genome-wide association study data.
    Heron EA; O'Dushlaine C; Segurado R; Gallagher L; Gill M
    Biostatistics; 2011 Jul; 12(3):445-61. PubMed ID: 21252078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance testing for small microarray experiments.
    Kooperberg C; Aragaki A; Strand AD; Olson JM
    Stat Med; 2005 Aug; 24(15):2281-98. PubMed ID: 15889452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method to increase the power of multiple testing procedures through sample splitting.
    Rubin D; Dudoit S; van der Laan M
    Stat Appl Genet Mol Biol; 2006; 5():Article19. PubMed ID: 17049030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
    Liu C; Shen W; Xie J
    Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical Bayes and resampling based multiple testing procedure controlling tail probability of the proportion of false positives.
    van der Laan MJ; Birkner MD; Hubbard AE
    Stat Appl Genet Mol Biol; 2005; 4():Article29. PubMed ID: 16646847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluations of the Optimal Discovery Procedure for Multiple Testing.
    Rubin DB
    Int J Biostat; 2016 May; 12(1):21-9. PubMed ID: 27227716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parametric and nonparametric FDR estimation revisited.
    Wu B; Guan Z; Zhao H
    Biometrics; 2006 Sep; 62(3):735-44. PubMed ID: 16984315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods for estimating the number of true null hypotheses in multiplicity testing.
    Hsueh HM; Chen JJ; Kodell RL
    J Biopharm Stat; 2003 Nov; 13(4):675-89. PubMed ID: 14584715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian optimal discovery procedure for simultaneous significance testing.
    Cao J; Xie XJ; Zhang S; Whitehurst A; White MA
    BMC Bioinformatics; 2009 Jan; 10():5. PubMed ID: 19126217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hierarchical Bayes models for cDNA microarray gene expression.
    Lönnstedt I; Britton T
    Biostatistics; 2005 Apr; 6(2):279-91. PubMed ID: 15772106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the geometric modeling approach to empirical null distribution estimation for empirical Bayes modeling of multiple hypothesis testing.
    Wu B
    Comput Biol Chem; 2013 Apr; 43():17-22. PubMed ID: 23314152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A computationally efficient modular optimal discovery procedure.
    Woo S; Leek JT; Storey JD
    Bioinformatics; 2011 Feb; 27(4):509-15. PubMed ID: 21186247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wavelet thresholding with bayesian false discovery rate control.
    Tadesse MG; Ibrahim JG; Vannucci M; Gentleman R
    Biometrics; 2005 Mar; 61(1):25-35. PubMed ID: 15737075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.